Healthcare intent signals.
A clue. Not a crystal ball.

A hospital executive researches workflow automation. A physician engages with content about remote monitoring. A healthcare organization shows increased activity around revenue cycle management.

Are they ready to buy?

Not necessarily.

They may be investigating a problem, preparing for a meeting, learning about a topic, evaluating an existing solution or researching on behalf of someone else.

The activity matters. But the conclusion matters more.

Healthcare intent signals are clues about potential relevance. They are not confirmation of a purchase.

If a vendor presents “intent detected” as equivalent to “ready to buy,” ask what evidence supports that leap.

Healthcare intent signals are observable activities or changes that suggest a person or organization may be interested in a topic, experiencing a relevant problem or exploring an initiative.

Depending on the source and how the data is collected, examples can include:

• Engagement with content about a healthcare topic.
• Repeated research into a technology or solution category.
• Visits to your own product, pricing or implementation pages.
• Participation in relevant events or webinars.
• Direct requests for information, demonstrations or proposals.

Other signals, such as leadership changes, hiring, acquisitions and expansion announcements, can provide useful context. They may reveal an opportunity to investigate, but they are not necessarily expressions of buying interest.

These signals differ in strength, specificity and attribution.

A webinar registration and a request for a proposal should not carry the same meaning.

Neither should activity attributed to a hospital and activity reliably linked to a named executive.

Before acting on a signal, understand what was observed, who it can reasonably be attributed to and what remains unknown.

No.

They cannot tell you with certainty:

• Whether an organization has approved a project.
• Whether funding is available.
• Whether the person engaging with a topic controls the purchase.
• Whether an incumbent supplier is being replaced.
• Whether the organization can complete procurement this quarter.
• Whether your solution meets its requirements.
• Whether the buyer will choose you.

Intent data can help you decide where to investigate and how to start a relevant conversation.

It cannot replace qualification, discovery or a credible offer.

The practical distinction is simple:

A signal can give you a reason to reach out. It does not give the recipient a reason to buy. Your conversation and offer still need to establish that.

Consider a physician reading about AI-assisted documentation.

That physician could be:

• Curious about the technology.
• Looking for ways to reduce documentation time.
• Comparing tools already available through their employer.
• Preparing an internal recommendation.
• Actively evaluating a purchase.

The topic is the same. The commercial situation is not.

A useful way to interpret activity is to distinguish three levels:

Movement between these levels is not automatic.

Repeated activity may strengthen a hypothesis. It does not prove the organization has moved into procurement.

Propensity scoring helps prioritize records according to a defined outcome or pattern.

Depending on the model, that might mean likelihood of engagement, fit with a target profile or similarity to accounts that previously progressed.

Those are different outcomes.

Before interpreting a score, ask:

1. What is the score designed to predict?
2. Is it an account score or an individual score?
3. Which signals contribute to it?
4. How recent are those signals?
5. Is the score a relative ranking or a calibrated probability?
6. How does the provider test whether it works?

A score of 85 does not automatically mean an 85% probability of purchase.

A “high propensity” label does not establish an approved budget.

For GTM teams, the value is prioritization: deciding where to spend research time, which questions to ask and which conversations might be more relevant.

Treat the score as a guide to investigation, not a substitute for evidence.

Healthcare purchases often involve people and organizations beyond the person who first shows interest.

An HCP may experience the problem and influence adoption without controlling the budget.

An executive may support an initiative but still need approval from finance, IT, security, procurement or clinical leadership.

A facility may sit within a broader Decision Network involving a health system, corporate owner, IDN, GPO or FQHC administrative team. The relevant relationships depend on the organization and the purchase.

For example, a physician’s interest in a clinical tool does not establish:

• Whether purchasing happens locally or centrally.
• Whether the tool must integrate with an existing EHR.
• Whether the organization has approved suppliers.
• Whether clinical, technical or financial review comes first.
• Whether other facilities share the same decision.

That is why intent becomes more useful when connected to identity, role, affiliations and organizational relationships.

The signal tells you where to look. The Decision Network helps you understand whom else to involve.

HCPs have limited time for messages that do not connect to their work. Healthcare executives face competing decisions and priorities.

A generic pitch asks the recipient to do the work:

Why are you contacting me? Why should I care? Why now?

A relevant message answers those questions quickly.

Intent signals can help you choose a topic that may matter to the recipient. Context helps you connect that topic to their role and situation.

But relevance is not the only ingredient. Credibility, clarity, trust and the effort required to respond also matter.

A thoughtful message can still arrive at the wrong time. A relevant problem can still have no available budget.

The goal is to earn a useful response, then learn what the signal could not tell you.

Suppose an account shows activity around patient access.

Sending the same “patient access solution” pitch to every contact misses the opportunity.

Different people may care about different parts of the problem:

These are hypotheses, not facts about the recipient.

Use them to prepare a conversation. Do not invent a problem simply because a topic appeared in your data.

1. Check the source and attribution

Establish whether the activity is linked to a person, an organization or a broader audience.

Do not turn an account-level signal into a claim about an individual.

If a hospital shows research activity, you cannot automatically conclude that its CIO personally conducted that research.

Also distinguish direct evidence, such as a demo request, from inferred interest.

2. Check recency and recurrence

When did the activity occur? Is it isolated or repeated? Does the topic remain relevant?

“Near real time” is only meaningful when you understand the collection, processing and update delays.

A recent signal may justify timely investigation. An old signal may still provide context, but should not be presented as current urgency.

3. Check fit

Does the account match your target market?

Does your offering address the topic in a meaningful way?

A strong signal from an unsuitable account does not become a good opportunity merely because the score is high.

4. Add the healthcare context

Review the organization, the contact’s role, relevant affiliations and the likely decision process.

Ask who might experience the problem, who could champion a change and who would need to approve it.

Do not assume those are the same person.

5. Offer something useful

Lead with a specific question, relevant insight, practical resource or credible example.

Give the person a reason to respond beyond “we sell this.”

6. Qualify through conversation

Once someone engages, establish:

• Is there a current problem?
• How important is it?
• What happens if nothing changes?
• Who owns the initiative?
• How would a purchase be funded?
• Which reviews and approvals are required?
• What is a realistic next step?

This is where potential relevance becomes a qualified opportunity.

7. Measure what the signals improve

Track more than opens and clicks.

Compare similar audiences and assess whether signal-informed outreach improves:

• Relevant replies.
• Conversations with appropriate stakeholders.
• Discovery of genuine initiatives.
• Progression to agreed next steps.
• Qualified opportunities.

If activity increases but qualification does not, revisit your targeting, interpretation and message.

Weak: assumes a purchase

“Your organization is showing strong intent for workflow automation. Can we book a demo?”

The message makes an unsupported assumption and immediately asks for time.

Better: tests a relevant problem

“When referral volume increases, manual routing can become difficult to manage. Is reducing that work a current priority for your team? If so, I can share a short checklist for evaluating the options.”

This creates an opening without pretending to know the recipient’s plans.

The example should still be adapted to evidence about the account. Do not claim referral growth unless you can support it.

For an HCP: respect the clinical workflow

“We put together a short guide to evaluating remote monitoring workflows, including escalation responsibilities and staff workload. Would it be useful for your team?”

For an executive: connect the topic to a decision

“If patient access is on your agenda, I can share a one-page framework for comparing workflow impact, integration requirements and implementation effort. Would that be relevant?”

These messages do not guarantee replies. They make it easier for the recipient to understand the value and indicate whether the topic matters.

Stop treating every signal as a buying trigger.
Some activity is educational, exploratory or unrelated to a purchase.

Stop telling people what they supposedly want.
Use the evidence to frame a question rather than declare a conclusion.

Stop confusing topic interest with permission to contact.
A signal does not establish consent or override channel preferences and suppression requirements.

Stop making timing claims the data cannot support.
A high score does not mean “buying this quarter.”

Stop expecting intent data to rescue an irrelevant offer.
If your solution does not fit the need, better targeting will not resolve that mismatch.

Intent.Health brings together organization, executive and HCP intelligence with Decision Networks, intent signals, propensity mapping and Ishi contextual intelligence.

The purpose is to help healthcare GTM teams connect the questions that are too often considered separately:

• Who fits our target market?
• What might matter to them?
• How are they connected to the wider organization?
• Which signals deserve investigation?
• What would make our outreach useful?

Signals and propensity can help prioritize attention. Ishi can help interpret the available context. Organization and relationship intelligence can help prepare a more informed conversation.

The sales work still matters.

You must establish the problem, understand the buying process, demonstrate value and earn agreement on the next step.

Our view is straightforward: intent intelligence should improve relevance, not manufacture certainty.

Explore Intent.Health or book a walkthrough to see how connected healthcare intelligence can support your GTM process.

Instead of asking:

“Who is showing intent, and how quickly can we pitch them?”

Ask:

“What does this signal actually tell us, what remains unknown, and what useful conversation could it help us start?”

That is how intent becomes valuable.

It opens a door to relevance. Your offer, credibility, timing, budget alignment and ability to solve the problem determine what happens next.